Why the study?
To highlight recent developments in CRISPR/Cas, focusing on CRISPR screens for studying viral infections and identifying new candidate genes to aid antiviral development.
Key points are not available for this paper at this time.
Design
Review
CRISPR screens may identify antiviral targets; leaves open clinical translation pending validation.
CRISPR/Cas is a powerful tool for studying the role of genes in viral infections. The invention of CRISPR screening technologies has made it possible to untangle complex interactions between the host and viral agents. Moreover, whole-genome and pathway-specific CRISPR screens have facilitated identification of novel drug candidates for treating viral infections. In this review, we highlight recent developments in the fields of CRISPR/Cas with a focus on the use of CRISPR screens for studying viral infections and identifying new candidate genes to aid development of antivirals.
No takes yet. Share an insight, caveat, or question.
Chulanov et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: